Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-30 Bruns Ingmar Chief Medical Officer Grant or award +9,727 $2.18 $21K 43,059
2026-02-09 Bruns Ingmar Chief Medical Officer Sale −335 $2.39 $802 33,332
2026-02-06 Bruns Ingmar Chief Medical Officer Sale −2,962 $2.43 $7K 33,667
2026-01-08 Bruns Ingmar Chief Medical Officer Grant or award · Stock Option (Right to Buy) +365,000 365,000
2025-02-06 Bruns Ingmar Chief Medical Officer Purchase +20,000 $2.28 $46K 36,629
2025-02-03 Bruns Ingmar Chief Medical Officer Grant or award +16,629 16,629
2025-02-03 Bruns Ingmar Chief Medical Officer Grant or award · Stock Option (Right to Buy) +16,629 16,629
2024-12-02 Bruns Ingmar Chief Medical Officer Grant or award · Stock Option (Right to Buy) +712,650 712,650

Page 1 of 1 · 8 trades